A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans

British Journal of Clinical Pharmacology

Volumn 61, Issue 2, 2006, Pages 138-147

  Magnusson, Marie ^a   Bergstrand, Ingar C ^a   Björkman, Sven ^a   Heijl, Anders ^a   Roth, Bodil ^a   Höglund, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ciprofloxacin; Metabolite effects; Pentoxifylline; Pharmacokinetics; Retinal blood flow; Rifampicin

Indexed keywords

CIPROFLOXACIN; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; PENTOXIFYLLINE; PLACEBO; RIFAMPICIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL; RETINA; RETINA BLOOD FLOW; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SYSTOLE;

ADULT; BLOOD FLOW VELOCITY; CIPROFLOXACIN; CYTOCHROME P-450 CYP1A2; DRUG INTERACTIONS; ENZYME INHIBITORS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LASER-DOPPLER FLOWMETRY; MALE; PENTOXIFYLLINE; RETINAL VESSELS; RIFAMPIN; VASODILATOR AGENTS;

EID: 33644909881     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02549.x     Document Type: Article

References (28)

1. Ward A Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy Drugs 1987 34 50 97
2. Samlaska CP Winfield A. Pentoxifylline J Am Acad Dermatol 1994 30 603 21
3. Moher D Pham B Ausejo M Saenz A Hood S Barber GG. Pharmacological management of intermittent claudication Drugs 2000 59 1057 70
4. Sonkin PL Sinclair SH Hatchell DL. The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity Am J Ophthalmol 1993 115 775 80
5. Sonkin PL Kelly LW Sinclair SH Hatchell DL. Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes Arch Ophthalmol 1993 111 1647 52
6. Sebag J Tang M Brown S Sadun AA Charles MA. Effects of pentoxifylline on choriodal blood flow in nonproliferative diabetic retinopathy Angiology 1994 45 429 33
7. Schmetterer L Kemmler D Breiteneder RN Alschinger C Koppensteiner R Lexer F Fercher AF Eichler H-G Wolzt M. A randomized, placebo-controlled, double-blind crossover study of the effects of pentoxifylline on ocular fundus pulsation Am J Ophthamol 1996 121 169 76
8. Kruger A Matulla B Woltz M Pieh S Strenn K Findl O Eichler H-G Schmetterer L. Short-term oral pentoxifylline use increases choriodal blood flow in patients with age related macular degeneration Arch Ophthalmol 1998 116 27 30
9. Hinze HJ Bedessem G Söder A. Struktur der Ausscheidungsprodukte des 3,7-Dimetyl-1-(5-oxo-hexyl)-xantins (BL 191) beim Menschen Arzneimittelforschung 1972 22 1144 51
10. Hinze HJ. Zur Pharmakokinetik von 3,7-Dimetyl-1-(5-oxo-hexyl)-xantin (BL 191) am Menchen Arzneimittelforschung 1972 22 1492 5
11. Smith RV Walker ES Doluisio JT Bauza MT Puri SK Ho I Lassman HB. Pharmacokinetics of orally administered pentoxifylline in humans J Pharm Sci 1986 75 47 52
12. 14C-pentoxifylline in healthy volunteers Arzneim-Forsch/Drug Res 1989 3 512 7
13. Lillibridge JA Kalhorn TF Slattery JT. Metabolism of lisofylline and pentoxifylline in human liver and cytosol Drug Metab Disp 1996 24 1174 9
14. Nicklasson M Björkman S Roth B Jönsson M Höglund P. Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans Chirality 2002 14 643 52
15. Ings RMJ Nüdemberg F Burrows JL Bryce TA. The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion Eur J Clin Pharmacol 1982 23 539 43
16. Ambrus JL Stadler S Kulaylat M. Hemorrheologic effects of metabolites of pentoxifylline (Trental) J Med 1995 26 65 75
17. Michelson G Schmasuss B. Two dimensional mapping of the perfusion of the retina and optic nerve head Br J Ophthamol 1995 79 1126 32
18. Fuhr U Anders EM Mahr G Sörgel F Staib AH. Inhibitory potency of quinolone antibacterial agents against cytochrome P4501A2 activity in vivo and in vitro Antimicrob Agents Chemother 1992 36 942 8
19. Peterson TC Peterson MR Wornell PA Blanchard MG Gonzalez FJ. Role of CYP 1A2 and CYP 2E1 in the pentoxifylline ciprofloxacin drug interaction Biochem Pharmacol 2004 68 395 402
20. Niemi M Backman JT Fromm MF Neuvonen PJ Kivistö KT. Pharmacokinetic interactions with rifampicin Clin Pharmacokinet 2003 42 819 50
21. Michelson G Welzenbach J Pal I Harzny J. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry Br J Ophthamol 1998 82 1294 300
22. Mauro VF Mauro LS Hageman JH. Comparison of pentoxifylline pharmacokinetics between smokers and nonsmokers J Clin Pharmacol 1992 32 1054 8
23. Zevin S Benowitz NL. Drug interaction with tobacco smoking. An update Clin Pharmacokinet 1999 36 425 38
24. Thompson JA Bianco JA Benyunes MC Neubauer MA Slattery JT Fefer A. Phase 1b trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma Cancer Res 1994 54 3436 41
25. Piscitelli SC Reiss WG Figg WD Petros WP. Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations Clin Pharmacokinet 1997 32 368
26. Schmetterer LF Lexer F Unfried CJ Sattmann H Fercher AF. Topical measurment of fundus pulsations Opt Engineering 1995 34 711 6
27. Delaey C Voorde JVD. Regulatory mechanisms in the retinal and choroidal circulation Ophthalmic Res 2000 32 249 56
28. Rice GC Brown PA Nelson RJ Bianco JA Singer JW Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid Proc Natl Acad Sci USA 1994 91 3857 61